15 aug: Ringkjøbing Landbobanks halvårsrapport for 1. halvår 2018
15 aug: William Demant Holding A/S: Halvårsrapport 2018
15-08-2018 03:37:00

Six-month interim report (Q2) 2018

Relateret indhold
14 sep - 
ALK-Abelló/Kempen: Reducerer til "sælg" og fastholder k..
14 sep - 
ALK-Abelló: Amerikanere reducerer sats på kursfald
13 sep - 
Torsdagens aktier: Japansk udfald mod Ambu trak aktien ..
Relateret debat
22 aug - 
Der hvor jeg tror man undervurderer potentialet er hast..
22 aug - 
Den har ihvertfald lavet et GC d. 08.06.2018, og både k..
22 aug - 
Alk brager nu igennem 1200. Men hvor langt skal den op ..

Better than expected performance in Q2 (unaudited)

ALK’s financial performance in Q2 was better than expected and full-year outlook has been improved. The execution of ALK’s new growth strategy is on track, with good progress being made on the commercialisation of SLIT-tablets – these saw 36% growth globally – and the US launch of ODACTRA™ progressing as planned. The roll-out of ALK’s new Consumer Care division and the ongoing drive for improved efficiencies are also advancing better than expected.

Q2 2018 highlights:

  • Total revenue was DKK 715 million (691). Revenue growth was 5% in local currencies. Exchange rates reduced reported revenue growth by approximately 2 percentage points.   
  • Global SLIT-tablet sales grew by 36% to DKK 183 million (134).  
  • Global SCIT/SLIT-drops sales were down 3% to DKK 410 million (426). The decline was largely attributable to planned portfolio rationalisations and the ongoing negative effect of previous production capacity constraints.
  • Operating profit (EBITDA) of DKK 10 million (16) was ahead of ALK's expectations and benefitted from higher than expected sales and faster than anticipated capture of operational efficiencies and savings.
  • In the first half-year, total revenue was DKK 1,467 million (1,480) and operating profit was DKK 102 million (156).
  • In the first half-year, free cash flow was minus DKK 201 million (minus 533).

Progress on the four strategic priorities

  1. In North America, the roll-out of ACARIZAX®/ODACTRA™ continues, and in the key US market, the increase in new patients and prescribers is progressing according to plan and managed care coverage expands better than planned.
  2. Commercialisation of the tablet portfolio gained momentum, with the robust uptake of ACARIZAX® continuing following further new launches and approvals. Meanwhile, a regulatory filing for the tree tablet in Europe is imminent and CEDARCURE™ has now been launched by ALK’s partner in Japan.  
  3. Patient engagement and Consumer Care division activities are on track and ALK has seen encouraging growth in web traffic on its digital platforms. The consumer platform klarify.me has been launched in a beta version in its first market as an important first step towards expanding ALK’s overall presence in allergy.
  4. The drive to optimise and reallocate resources is delivering operational efficiencies. At the same time, output and inventories of SCIT and SLIT-drops have been normalised and robustness in Product Supply is improving and now stabilised. Work to trim the product portfolio continues.

Improved 2018 financial outlook

Full-year outlook has slightly improved compared with the Q1 report, which was released on 4 May 2018.

  • Full-year revenue is now projected to be more than DKK 2.8 billion (previously: more than DKK 2.7 billion).
  • Operating profit (EBITDA) is now expected at around DKK 50 million (previously around DKK 0), reflecting the better than expected performance in the first half-year and more clarity on market conditions in Southern Europe.
  • ALK will continue to invest significantly in the strategic transformation of the company in the second half-year.  
  • Free cash flow is now expected at around minus DKK 550 million or better (previously: minus DKK 600 million or better).

Hørsholm, 15 August 2018

ALK-Abelló A/S

Comparative figures for 2017 are shown in brackets. G

rowth rates are stated in local currencies, unless otherwise indicated

For further information, contact:

Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525

Media: Jeppe Ilkjær, tel. +45 7877 4532, mobile +45 3050 2014

Today, ALK is hosting a conference call for analysts and investors at 1.30 p.m. (CEST) at which Management will review the financial results and the outlook. The conference call will be audio cast on https://ir.alk.net/. Participants for the audio cast are kindly requested to call in before 1.25 p.m. (CEST). Danish participants should call in on tel.

+45 7022 3500 and international participants should call in on tel. +44 (0) 20 7572 1187 or +1 646 722 4972.

Please use the Participant Pin Code: 95314096#. The conference call will also be webcast live on our website, where the related presentation will be made available shortly before the call begins.

Attachment

Primary Logo

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Aktier/tendens: Danske Bank og Mærsk stjæler billedet

19-09-2018 08:24:00
Danske Bank og A.P. Møller-Mærsk vil på hver sin baggrund tage en stor del af opmærksomheden på det danske aktiemarked onsdag. Men også Ørsted vil blande sig i løjerne.Danske Bank-ledelsen fremlægger konklusionerne af en intern undersøgelse af den omfattende hvidvask af penge, der er foregået i Danske Banks estiske filial. Samtidig offentliggør A.P. Møller-Mærsk en længe ventet større organisation..

Coloplast/dir: Skift i ambitionsniveauet er afgørende for væksten

18-09-2018 15:10:18
Den danske medicokoncern Coloplast har taget de første skridt i strategien om at få højere priser for klinisk dokumenterede produkter, og det kommer til at spille en afgørende rolle for selskabets vækst i fremtiden.- Det er ekstremt vigtigt. Vi opfatter det her skifte i ambitionsniveauet som afgørende for, at vi kan forøge vækstmomentum, siger Kristian Villumsen, der er direktør for den kroniske f..

Mærsk/analytikere: Frasalg trak lidt ud men er nu så godt som i mål

18-09-2018 13:45:01
Når A.P. Møller-Mærsk næste år er klar til at sende Maersk Drilling, som ejer rigge og skibe, der borer efter olie og gas til havs på vegne af olieselskaberne, på børsen som et selvstændigt selskab, er koncernen også så godt som i mål med den ene del af strategien, som blev lanceret i 2016.På lørdag er det præcis to år siden, at Mærsk løftede sløret for en ny strategi, der skulle være med til at t..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Danske Banks største ejer: Tid til at kigge fremad og lære af sagen
2
Aktier/tendens: Danske Bank og Mærsk stjæler billedet
3
Danske Bank: Tusindvis kunder er indberettet til myndighederne - NY2
4
Danske Bank donerer 1,5 mia. fra hvidvaskportefølje og nedjusterer-NY2
5
Danske Bank/Jyske: Omfangsloft er løftet - stadig meget usikkerhed

Relaterede aktiekurser

ALK-Abelló B A/S 1.116,00 -0,4% Fald i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Berlingske Media 2018  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
19. september 2018 20:49:57
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180919.1 - EUROWEB4 - 2018-09-19 20:49:57 - 2018-09-19 20:49:57 - 1 - Website: OKAY